Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure
Authors:
- G G KonduriGKG G Konduri
- N AmbalavananNAN Ambalavanan
- T LeeTLT Lee
- A SolimanoASA Solimano
Open Access
- 18 July 2013
- journal article
- research article
- Published by Springer Nature in Journal of Perinatology
- Vol. 33 (12) , 944-949
Abstract
Objective: Study design: Result: Conclusion:Keywords
This publication has 24 references indexed in Scilit:
- Morbidity and Mortality in Late Preterm Infants with Severe Hypoxic Respiratory Failure on Extra-Corporeal Membrane OxygenationThe Journal of Pediatrics, 2011
- Advances in the Diagnosis and Management of Persistent Pulmonary Hypertension of the NewbornPediatric Clinics of North America, 2009
- The Epidemiology of Respiratory Failure in Neonates Born at an Estimated Gestational Age of 34 Weeks or MoreJournal of Perinatology, 2004
- Interactive effects of high-frequency oscillatory ventilation and inhaled nitric oxide in acute hypoxemic respiratory failure in pediatricsCritical Care Medicine, 2002
- Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the NewbornNew England Journal of Medicine, 2000
- Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trialThe Lancet, 1999
- Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failureThe Journal of Pediatrics, 1998
- Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the NewbornNew England Journal of Medicine, 1997
- Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory FailureNew England Journal of Medicine, 1997
- UK collaborative randomised trial of neonatal extracorporeal membrane oxygenationThe Lancet, 1996